These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11295795)

  • 1. Case with both multiple system atrophy and primary progressive multiple sclerosis with discussion of the difficulty in their differential diagnosis.
    Chuang C; Kocen RS; Quinn NP; Daniel SE
    Mov Disord; 2001 Mar; 16(2):355-8. PubMed ID: 11295795
    [No Abstract]   [Full Text] [Related]  

  • 2. 69-year-old man with gait disturbance and Parkinsonism.
    Marras C; Lang AE; Ang LC; Zijlmans J; Wenning GK
    Mov Disord; 2001 May; 16(3):548-61. PubMed ID: 11391758
    [No Abstract]   [Full Text] [Related]  

  • 3. Brainstem glioblastoma in a patient with secondary progressive multiple sclerosis.
    Mantero V; Balgera R; Bianchi G; Rossi G; Rigamonti A; Fiumani A; Salmaggi A
    Neurol Sci; 2015 Sep; 36(9):1733-5. PubMed ID: 25990103
    [No Abstract]   [Full Text] [Related]  

  • 4. Myoclonic tremor in patients with parkinsonian-type multiple system atrophy.
    Okuma Y; Mizuno Y
    Mov Disord; 2001 Mar; 16(2):378-9. PubMed ID: 11295804
    [No Abstract]   [Full Text] [Related]  

  • 5. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
    Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
    Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinsonism/dystonia syndrome secondary to multiple sclerosis with anti-basal-ganglia antibodies.
    Delgado S; Baez S; Singer C; Sengun C; Sheremata WA; Papapetropoulos S
    Mov Disord; 2009 Jan; 24(2):309-11. PubMed ID: 18951536
    [No Abstract]   [Full Text] [Related]  

  • 7. Pontine MRI hyperintensities ("the cross sign") are not pathognomonic for multiple system atrophy (MSA).
    Bürk K; Skalej M; Dichgans J
    Mov Disord; 2001 May; 16(3):535. PubMed ID: 11391754
    [No Abstract]   [Full Text] [Related]  

  • 8. Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosis.
    Caon C; Zvartau-Hind M; Ching W; Lisak RP; Tselis AC; Khan OA
    Neurology; 2003 Jan; 60(2):323-5. PubMed ID: 12552053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystonia in multiple system atrophy.
    Riley DE
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):286. PubMed ID: 11861681
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathological correlate of the slitlike changes on MRI at the putaminal margin in multiple system atrophy.
    Konagaya M; Sakai M; Matsuoka Y; Goto Y; Yoshida M; Hashizume Y
    J Neurol; 1999 Feb; 246(2):142-3. PubMed ID: 10195412
    [No Abstract]   [Full Text] [Related]  

  • 11. "Hot cross bun" sign in a patient with parkinsonism secondary to presumed vasculitis.
    Muqit MM; Mort D; Miskiel KA; Shakir RA
    J Neurol Neurosurg Psychiatry; 2001 Oct; 71(4):565-6. PubMed ID: 11601421
    [No Abstract]   [Full Text] [Related]  

  • 12. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
    Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL
    Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A young patient with type C multiple system atrophy and hereditary hemochromatosis.
    Di Filippo M; Floridi P; Rossi V; Mattucci E; Rossi A; Calabresi P; Tambasco N
    J Neurol; 2010 Feb; 257(2):294-5. PubMed ID: 19826858
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical diagnostic criteria for multiple system atrophy].
    Vidailhet M; Bonnet AM; Agid Y
    Rev Neurol (Paris); 1998 Jan; 154(1):17-21. PubMed ID: 9773020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI.
    Schott JM; Simon JE; Fox NC; King AP; Khan MN; Cipolotti L; Paviour DC; Stevens JM; Rossor MN
    Mov Disord; 2003 Aug; 18(8):955-8. PubMed ID: 12889090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion tensor MRI of the cervical cord in a patient with syringomyelia and multiple sclerosis.
    Agosta F; Rovaris M; Benedetti B; Valsasina P; Filippi M; Comi G
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1647. PubMed ID: 15489410
    [No Abstract]   [Full Text] [Related]  

  • 18. Parkinson's disease with Onuf's nucleus involvement mimicking multiple system atrophy.
    O'Sullivan SS; Holton JL; Massey LA; Williams DR; Revesz T; Lees AJ
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):232-4. PubMed ID: 17951280
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of MRI in the evaluation of secondary progressive multiple sclerosis.
    Brown JW; Chard DT
    Expert Rev Neurother; 2016; 16(2):157-71. PubMed ID: 26692498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyramidal tract degeneration in multiple system atrophy: the relevance of magnetization transfer imaging.
    da Rocha AJ; Maia AC; da Silva CJ; Braga FT; Ferreira NP; Barsottini OG; Ferraz HB
    Mov Disord; 2007 Jan; 22(2):238-44. PubMed ID: 17133514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.